ImmuneMed
Immunemed Inc. is dedicated to high-tech research and sound management, focusing on human health and welfare by developing diagnostic kits and antiviral substances. The company aims to become a globally trusted leader in infectious disease diagnostics and therapeutics, with a mission to address incurable and obstinate diseases through innovative research and development. The company also emphasizes the development of antiviral therapeutics based on Virus Suppressing Factor (VSF), a potent broad-spectrum antiviral substance, and is engaged in rapid diagnosis and vaccine development for acute febrile illnesses.
Industries
Nr. of Employees
medium (51-250)
ImmuneMed
Room #2-2, Bldg. #3 Chuncheon BioTown, 32 Soyanggangro, Chuncheon-si, Gangwon-do, Republic of Korea
Patents
Method for treating skin diseases using a humanized antibody that binds to vimentin
US-11649277-B2
View DetailsAntibody specifically binding to an isolated peptide derived from vimentin or a fragment binding to the peptide
US-10961300-B2
View Details
Method for treating skin diseases using a humanized antibody that binds to vimentin
US-11649277-B2
View DetailsAntibody specifically binding to an isolated peptide derived from vimentin or a fragment binding to the peptide
US-10961300-B2
View DetailsProducts
Rapid lateral-flow IgM/IgG test for Leptospira
Qualitative lateral-flow assay for detection of anti-Leptospira IgM and IgG in serum, plasma or whole blood; small sample volumes and ~15-minute read time for POC screening.
Rapid lateral-flow IgM/IgG test for scrub typhus
Qualitative lateral-flow assay for detection of anti-Orientia tsutsugamushi IgM and IgG in serum, plasma or whole blood with ~15-minute read time and equipment-free interpretation.
Rapid lateral-flow IgM/IgG test for hantavirus (HFRS)
Lateral-flow assay for detection of antibodies against Hantaan/Seoul viruses in serum, plasma or whole blood; ~15-minute read time.
Rapid lateral-flow IgM/IgG test for murine typhus (Rickettsia typhi)
Qualitative lateral-flow assay for anti-Rickettsia typhi antibodies in serum, plasma or whole blood with ~10–15-minute read time for POC differentiation.
AFI multiplex rapid lateral-flow test
Single-test multiplex lateral-flow assay to screen for multiple acute febrile illness pathogens with IgM/IgG differentiation and ~10–15-minute read times.
Dengue NS1 antigen rapid test
Lateral-flow antigen test for qualitative detection of dengue NS1 antigen in serum, plasma or whole blood; optimized for early POC detection with ~20-minute read time.
Rapid lateral-flow IgM/IgG test for Leptospira
Qualitative lateral-flow assay for detection of anti-Leptospira IgM and IgG in serum, plasma or whole blood; small sample volumes and ~15-minute read time for POC screening.
Rapid lateral-flow IgM/IgG test for scrub typhus
Qualitative lateral-flow assay for detection of anti-Orientia tsutsugamushi IgM and IgG in serum, plasma or whole blood with ~15-minute read time and equipment-free interpretation.
Rapid lateral-flow IgM/IgG test for hantavirus (HFRS)
Lateral-flow assay for detection of antibodies against Hantaan/Seoul viruses in serum, plasma or whole blood; ~15-minute read time.
Rapid lateral-flow IgM/IgG test for murine typhus (Rickettsia typhi)
Qualitative lateral-flow assay for anti-Rickettsia typhi antibodies in serum, plasma or whole blood with ~10–15-minute read time for POC differentiation.
AFI multiplex rapid lateral-flow test
Single-test multiplex lateral-flow assay to screen for multiple acute febrile illness pathogens with IgM/IgG differentiation and ~10–15-minute read times.
Dengue NS1 antigen rapid test
Lateral-flow antigen test for qualitative detection of dengue NS1 antigen in serum, plasma or whole blood; optimized for early POC detection with ~20-minute read time.
Services
R&D services for design and development of lateral-flow assays for serology, antigen detection and biomarker-based toxicant detection, including reagent preparation and assay optimization.
On-site production and packaging of lateral-flow diagnostic kits including cassette assembly, conjugate pads, sample diluents and instructional materials; experience with international distribution.
Preparation of performance documentation (sensitivity/specificity), QC protocols and submission materials for national regulatory review and approval of in vitro diagnostics.
Discovery and characterization of antiviral candidates, execution of non-clinical efficacy studies, preparation for clinical evaluation and partner licensing management.
R&D services for design and development of lateral-flow assays for serology, antigen detection and biomarker-based toxicant detection, including reagent preparation and assay optimization.
On-site production and packaging of lateral-flow diagnostic kits including cassette assembly, conjugate pads, sample diluents and instructional materials; experience with international distribution.
Preparation of performance documentation (sensitivity/specificity), QC protocols and submission materials for national regulatory review and approval of in vitro diagnostics.
Discovery and characterization of antiviral candidates, execution of non-clinical efficacy studies, preparation for clinical evaluation and partner licensing management.
Expertise Areas
- Point-of-care rapid diagnostics
- Lateral-flow immunoassay development and manufacturing
- Multiplex diagnostics for acute febrile illness
- Serological (IgM/IgG) and antigen rapid testing
Key Technologies
- Lateral-flow immunoassays
- Antigen-detection assays
- IgM/IgG serology assays
- Gold and latex conjugate labelling
News & Updates
Patent registered in the USA on April 7, 2009, with registration number 7,514,082.
Patent application filed in China on December 9, 2009, with registration number 101600965200780050927.
Patent registered in the USA on April 7, 2009, with registration number 7,514,082.
Patent application filed in China on December 9, 2009, with registration number 101600965200780050927.